Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
- PMID: 33125712
- PMCID: PMC8199792
- DOI: 10.1111/bph.15299
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Abstract
The known seven mammalian receptor subunits (P2X1-7) form cationic channels gated by ATP. Three subunits compose a receptor channel. Each subunit is a polypeptide consisting of two transmembrane regions (TM1 and TM2), intracellular N- and C-termini, and a bulky extracellular loop. Crystallization allowed the identification of the 3D structure and gating cycle of P2X receptors. The agonist-binding pocket is located at the intersection of two neighbouring subunits. In addition to the mammalian P2X receptors, their primitive ligand-gated counterparts with little structural similarity have also been cloned. Selective agonists for P2X receptor subtypes are not available, but medicinal chemistry supplied a range of subtype-selective antagonists, as well as positive and negative allosteric modulators. Knockout mice and selective antagonists helped to identify pathological functions due to defective P2X receptors, such as male infertility (P2X1), hearing loss (P2X2), pain/cough (P2X3), neuropathic pain (P2X4), inflammatory bone loss (P2X5), and faulty immune reactions (P2X7).
Keywords: (patho)physiological functions; P2X receptors; agonists; antagonists; extracellular ATP; knockout mice; ligand-gated cationic channels.
© 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Conflict of interest statement
CONFLICT OF INTEREST
F.D.V. is a member of the Scientific Advisory Board of Biosceptre Ltd, a UK-based biotech company involved in the development of P2X7-targeted therapeutic antibodies. The other authors declare no competing interest.
Figures
References
-
- Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, … Weisman GA (2006). International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy. Pharmacological Reviews, 58, 281–341. 10.1124/pr.58.3.3 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 335447717-SFB 1328/Deutsche Forschungsgemeinschaft
- 8YTNWC/Ministry of University and Research
- Z01 DK031127/ImNIH/Intramural NIH HHS/United States
- 13025/Italian Association for Cancer Research
- G20190236012/State Administration of Foreign Experts Affairs
- CZYHW1901/Chengdu University of Traditional Chinese Medicine
- IG 22883/Associazione Italiana per la Ricerca sul Cancro
- IG 13025/Associazione Italiana per la Ricerca sul Cancro
- Università degli Studi di Ferrara
- 766124/European Union's Horizon 2020
- Horizon 2020 Framework Programme
- IG 18581/Associazione Italiana per la Ricerca sul Cancro
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
